Clinical Research Directory
Browse clinical research sites, groups, and studies.
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
Sponsor: Thomas Jefferson University
Summary
This is an open-label, non-randomized study conducted at Thomas Jefferson University comparing pressure-gradient estimates (obtained between a carotid plaque and the carotid artery) to imaging and histology markers of plaque vulnerability. There is an inverse relationship between the subharmonic signal magnitude from contrast-enhanced ultrasound microbubbles and ambient pressure. This pressure estimation technique (referred as SHAPE) will be used to estimate the pressure gradient across the carotid plaque cap noninvasively in vivo.
Official title: Risk Assessment of Carotid Plaques Based on Pressure Estimation Using 3D Contrast-enhanced Ultrasound
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
20
Start Date
2020-12-01
Completion Date
2025-12-31
Last Updated
2025-04-24
Healthy Volunteers
No
Conditions
Interventions
Perflutren
The ultrasound contrast agent is used to improve the quality of ultrasound imaging and is infused over 5-10 minutes. The contrast agent consists of the gas-filled microbubbles smaller than the capillary size which circulate in the vascular system. The contrast agent is cleared from the body naturally within 30 minutes.
Locations (1)
Thomas jefferson University
Philadelphia, Pennsylvania, United States